BioLineRx Ltd. (BLRX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.56
Day's range
$2.75

Bioline Rx Ltd Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
XTX TOPCO LTD 05/15/2026 10.94 K $25.27 K   100.00% 0.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 10.20 K $23.56 K   100.00% 0.25%
RHUMBLINE ADVISERS 05/12/2026 2.35 K $5.43 K   -29.82% 0.06%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 1.80 K $4.14 K   20.00% 0.04%
WELLS FARGO & COMPANY/MN 05/11/2026 1.75 K $4.03 K   0.00% 0.04%
CITIGROUP INC 05/11/2026 1.73 K $3.99 K   -15.21% 0.04%
UBS GROUP AG 05/05/2026 529 $1.22 K   -72.89% 0.01%
NEMES RUSH GROUP LLC 04/21/2026 250 $575   0.00% 0.01%
NEWEDGE ADVISORS, LLC 06/03/2026 107 $247   0.00% 0.00%
MORGAN STANLEY 05/15/2026 100 $230   0.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 05/15/2026 26 $59   0.00% 0.00%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 05/14/2026 12 $28   0.00% 0.00%
DANSKE BANK A/S 05/12/2026 2 $5   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/18/2026 0 $0   -100.00% 0.00%
CITADEL ADVISORS LLC 05/15/2026 0 $0   -100.00% 0.00%

Bioline Rx Ltd institutional Ownership - FAQ's

During the previous two years, 19 institutional investors and hedge funds held shares of Bioline Rx Ltd. The most heavily invested institutionals were:

XTX Topco Ltd: 10,941

RHUMBLINE ADVISERS: 2,353

BNP PARIBAS ARBITRAGE, SNC: 1,800

WELLS FARGO & COMPANY/MN: 1,750

CITIGROUP INC: 1,728

UBS Group AG: 529

0.48% of Bioline Rx Ltd stock is owned by institutional investors.

Institutional investors have bought a total of 848.70 K shares in the last 24 months. This purchase volume represents approximately $2.25 M in transactions.